Moderate Exposure to Allogeneic Blood Products Is Not Associated With Reduced Long-Term Survival After Surgery for Coronary Artery Disease
Anesthesiology - United States
doi 10.1097/aln.0b013e3181ab6743
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)